http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1001001-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_141eb5666668dc9f69f047e33ffbe90f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-10 |
| filingDate | 1987-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1989-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1989-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BE-1001001-A5 |
| titleOfInvention | Pharmaceutical compositions having central nervous system activity. |
| abstract | Pharmaceutical preparation, resistant for oral administration, characterized in that it contains oytin-diphospho-dimethyl-ethanolamine (CDP-deanol) as an active ingredient, mixed with a pharmaceutically acceptable carrier or excipient. |
| priorityDate | 1986-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.